Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ADMA Biologics Inc (ADMA : NSDQ)

• Company Description    ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey. Number of Employees: 685

• Price / Volume Information    Yesterday's Closing Price: $16.11 Daily Weekly Monthly 20 Day Moving Average: 2,797,155 shares Shares Outstanding: 238.63 (millions) Market Capitalization: $3,844.35 (millions) Beta: 0.54 52 Week High: $25.67 52 Week Low: $13.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.07% -6.74% 12 Week -11.14% -19.29% Year To Date -6.06% -16.13%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 465 STATE ROUTE 17 - RAMSEY,NJ 07446 USA ph: 201-478-5552 fax: 201-478-5553 michelle@argotpartners.com http://www.admabiologics.com

• General Corporate Information    Officers Adam S. Grossman - President and Chief Executive Officer Steven A. Elms - Chairman Jerrold B. Grossman - Vice Chairman Brad Tade - Chief Financial Officer Alison Finger - Director Peer Information ADMA Biologics Inc (CORR.) ADMA Biologics Inc (RSPI) ADMA Biologics Inc (CGXP) ADMA Biologics Inc (BGEN) ADMA Biologics Inc (GTBP) ADMA Biologics Inc (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 000899104 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 238.63 Most Recent Split Date: (:1) Beta: 0.54 Market Capitalization: $3,844.35 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.16 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.63 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: 25.57 Trailing 12 Months: 27.78 PEG Ratio: - Price Ratios Price/Book: 9.65 Price/Cash Flow: 29.76 Price / Sales: 8.11 EPS Growth vs. Year Ago Period: 15.38% vs. Previous Quarter: 7.14% Sales Growth vs. Year Ago Period: 13.80% vs. Previous Quarter: 6.26% ROE 06/30/25 - 41.01 03/31/25 - 47.16 12/31/24 - 51.67 ROA 06/30/25 - 28.47 03/31/25 - 30.51 12/31/24 - 29.68 Current Ratio 06/30/25 - 5.33 03/31/25 - 6.58 12/31/24 - 5.97 Quick Ratio 06/30/25 - 2.78 03/31/25 - 3.36 12/31/24 - 2.90 Operating Margin 06/30/25 - 29.25 03/31/25 - 29.32 12/31/24 - 27.96 Net Margin 06/30/25 - 44.06 03/31/25 - 45.01 12/31/24 - 46.35 Pre-Tax Margin 06/30/25 - 30.58 03/31/25 - 30.64 12/31/24 - 29.48 Book Value 06/30/25 - 1.67 03/31/25 - 1.57 12/31/24 - 1.48 Inventory Turnover 06/30/25 - 1.26 03/31/25 - 1.26 12/31/24 - 1.18 Debt-to-Equity 06/30/25 - 0.21 03/31/25 - 0.22 12/31/24 - 0.23 Debt-to-Capital 06/30/25 - 17.19 03/31/25 - 17.79 12/31/24 - 18.82

Powered by Zacks Investment Research ©